Abner Tagoola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Abner Tagoola has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Asdo
Faculty of Science, University of British Columbia, Vancouver, BC, Canada
1 shared publication - Alishah Mawji
Affiliations Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada, Centre for International Child Health, BC Children’s Hospital Research Institute, Vancouver, British Columbia, Canada
1 shared publication - Andrea L. Conroy
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA
1 shared publication - Andrew Abutu
CDC: Centers for Disease Control and Prevention
1 shared publication - Austin Demby
Government of Sierra Leone Ministry of Health and Sanitation: Ministry of Health and Sanitation
1 shared publication - Basil Uguge
JHPIEGO corporation
1 shared publication
Latest Publications
- Open Access
Evaluation of Sierra Leone’s Elimination of Mother-to-child Transmission of HIV Program, 2024: The Need for a Life Course Approach to Triple Elimination
Background: The elimination of Mother-to-Child Transmission (eMTCT) Cascade Analysis is a key intervention to understand the effectiveness and gaps in national HIV prevention programs for pregnant women and their infants. This comprehensive evaluation aimed to assess the step-by-step processes of eMTCT services, from the entry points at antenatal care (ANC) to outcomes for HIV-exposed infants (HEI) and propose actionable recommendations using the life course approach to improve maternal and child health outcomes in Sierra Leone. Methods: We used a retrospective cohort study to understand the entry of HIV-positive pregnant women into the eMTCT program and the outcome of their infants. The assessment was conducted in June 2024 across 118 selected health facilities nationwide. Data was analysed using Microsoft Excel to assess the steps from entry into the eMTCT program to HIV testing outcomes and delivery process for infants, including final infant/child outcomes for HIV-positive pregnant and breastfeeding women. Results: Of the 80,264 pregnant women attending their first ANC visit between January and December 2022, 74,401(92.7%) received HIV tests. Of the 2,083 newly diagnosed HIV-positive pregnant women, 1,612 (77.4%) were initiated on antiretroviral therapy (ART) at their first ANC visit, highlighting a critical gap where 22.6% missed early treatment initiation. Only 753 (36.1%) HIV-positive women had documented facility-based delivery, indicating significant drop-offs in retention and continuity of care. Among 761 HEIs, 671 (88.2%) received ART for prophylaxis within 72 hours of birth; however, only 466 (61.2%) underwent their first virological test within 6-8 weeks of birth, and 176 (24.1%) received a second virological test 12 weeks after cessation of breastfeeding. Conclusion: While Sierra Leone’s eMTCT program has made substantial progress in ANC attendance and HIV testing, critical gaps persist in ART initiation, facility delivery of HIV-positive women and retention in care. Adopting a life course approach is critical to address these gaps through targeted interventions, improved data quality, and enhanced follow-up care.
Open AccessEvaluation of Sierra Leone’s Elimination of Mother-to-child Transmission of HIV Program, 2024: The Need for a Life Course Approach to Triple Elimination
Background: The elimination of Mother-to-Child Transmission (eMTCT) Cascade Analysis is a key intervention to understand the effectiveness and gaps in national HIV prevention programs for pregnant women and their infants. This comprehensive evaluation aimed to assess the step-by-step processes of eMTCT services, from the entry points at antenatal care (ANC) to outcomes for HIV-exposed infants (HEI) and propose actionable recommendations using the life course approach to improve maternal and child health outcomes in Sierra Leone. Methods: We used a retrospective cohort study to understand the entry of HIV-positive pregnant women into the eMTCT program and the outcome of their infants. The assessment was conducted in June 2024 across 118 selected health facilities nationwide. Data was analysed using Microsoft Excel to assess the steps from entry into the eMTCT program to HIV testing outcomes and delivery process for infants, including final infant/child outcomes for HIV-positive pregnant and breastfeeding women. Results: Of the 80,264 pregnant women attending their first ANC visit between January and December 2022, 74,401(92.7%) received HIV tests. Of the 2,083 newly diagnosed HIV-positive pregnant women, 1,612 (77.4%) were initiated on antiretroviral therapy (ART) at their first ANC visit, highlighting a critical gap where 22.6% missed early treatment initiation. Only 753 (36.1%) HIV-positive women had documented facility-based delivery, indicating significant drop-offs in retention and continuity of care. Among 761 HEIs, 671 (88.2%) received ART for prophylaxis within 72 hours of birth; however, only 466 (61.2%) underwent their first virological test within 6-8 weeks of birth, and 176 (24.1%) received a second virological test 12 weeks after cessation of breastfeeding. Conclusion: While Sierra Leone’s eMTCT program has made substantial progress in ANC attendance and HIV testing, critical gaps persist in ART initiation, facility delivery of HIV-positive women and retention in care. Adopting a life course approach is critical to address these gaps through targeted interventions, improved data quality, and enhanced follow-up care.
- Open Access
Repeatability of Pulse Oximetry Measurements in Children During Triage in Two Ugandan Hospitals
Background: In low- and middle-income countries, health workers use pulse oximeters for intermittent spot measurements of SpO 2 . However, the accuracy and reliability when used for spot measurements has not been determined. We evaluated the repeatability of spot measurements, and the ideal observation time of measurement to guide recommendations during spot check measurements. Methods: Two one-minute measurements were done for the 3,903 subjects enrolled in the study, collecting 1Hz SpO 2 and signal quality index (SQI) data. The repeatability between the two measurements was assessed using an intraclass correlation coefficient (ICC), calculated using a median of all seconds of non-zero SpO 2 values for each recording (any quality, Q1), and again with a quality filter only using seconds with SQI ≥ 90% (good quality, Q2). The ICC was also calculated for both these conditions using subsets of the minute, in increasing increments of 5 seconds, up to the whole minute. Lastly, the whole minute ICC was calculated with good quality (Q2), including only records where both measurements had a mean SQI > 70% (Q3). Findings: The repeatability ICC with condition Q1 was 0.591 (95% confidence interval (CI) = 0.570, 0.611). Using only the first 5 seconds of each measurement reduced the repeatability to 0.200 (95% CI = 0.169, 0.230). Filtering with Q2, the whole minute ICC was 0.855 (95% CI = 0.847, 0.864). The ICC did not improve beyond the first 35 seconds. For Q3, the repeatability rose to 0.908 (95% CI = 0.901, 0.914). Conclusions: Training guidelines must emphasize the importance of signal quality and duration of measurement, targeting a minimum of 35 seconds of adequate-quality, stable data. In addition, the design of new devices should incorporate user prompts and force quality checks to encourage more accurate pulse oximetry measurement. Trial Registration: Clinical Trials.gov Identifier: NCT04304235 , Registered 11 March 2020.
Open AccessRepeatability of Pulse Oximetry Measurements in Children During Triage in Two Ugandan Hospitals
Background: In low- and middle-income countries, health workers use pulse oximeters for intermittent spot measurements of SpO 2 . However, the accuracy and reliability when used for spot measurements has not been determined. We evaluated the repeatability of spot measurements, and the ideal observation time of measurement to guide recommendations during spot check measurements. Methods: Two one-minute measurements were done for the 3,903 subjects enrolled in the study, collecting 1Hz SpO 2 and signal quality index (SQI) data. The repeatability between the two measurements was assessed using an intraclass correlation coefficient (ICC), calculated using a median of all seconds of non-zero SpO 2 values for each recording (any quality, Q1), and again with a quality filter only using seconds with SQI ≥ 90% (good quality, Q2). The ICC was also calculated for both these conditions using subsets of the minute, in increasing increments of 5 seconds, up to the whole minute. Lastly, the whole minute ICC was calculated with good quality (Q2), including only records where both measurements had a mean SQI > 70% (Q3). Findings: The repeatability ICC with condition Q1 was 0.591 (95% confidence interval (CI) = 0.570, 0.611). Using only the first 5 seconds of each measurement reduced the repeatability to 0.200 (95% CI = 0.169, 0.230). Filtering with Q2, the whole minute ICC was 0.855 (95% CI = 0.847, 0.864). The ICC did not improve beyond the first 35 seconds. For Q3, the repeatability rose to 0.908 (95% CI = 0.901, 0.914). Conclusions: Training guidelines must emphasize the importance of signal quality and duration of measurement, targeting a minimum of 35 seconds of adequate-quality, stable data. In addition, the design of new devices should incorporate user prompts and force quality checks to encourage more accurate pulse oximetry measurement. Trial Registration: Clinical Trials.gov Identifier: NCT04304235 , Registered 11 March 2020.
- Open Access
- 26 July 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-11
Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS): study protocol for a randomized placebo-controlled trial in Ugandan children with sickle cell anemia
Sickle cell anemia (SCA) is the most common inherited hemoglobinopathy worldwide. Infection is a major cause of illness and death in children with SCA, especially in sub-Saharan Africa where an estimated 50–90% of affected children die before their fifth birthday. Interventions to reduce the incidence and severity of infections are needed urgently. A high proportion of adults and children with SCA are zinc-deficient, and zinc deficiency leads to impaired immunity and an increased risk of infection. Zinc supplementation has been shown to decrease the risk of infection in adolescents and adults, but there are no data on the effectiveness of zinc for prevention of infection in children < 5 years of age with SCA. The study will be a randomized, placebo-controlled, double-blind clinical trial in which 250 Ugandan children 1.00–4.99 years of age with SCA will receive daily zinc supplementation (10 mg oral dispersible tablet) or identical placebo for 12 months. If this trial shows a reduction in severe or invasive infection incidence, it would be the basis for a multi-site, multi-country clinical trial to assess real-world safety and efficacy of zinc in African children with SCA. Since zinc is safe, inexpensive, and easy to administer, this trial has the potential to improve the health of hundreds of thousands of African children with SCA through reduction of infection-related morbidity and mortality. Clinicaltrials.gov, NCT03528434. Registered on May 17, 2018 Protocol Version: 1.0. Date: Dec 11, 2017 Sponsor: Indiana University. Sponsor’s protocol identifier, 1712339562
- 26 July 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-11
Open AccessZinc for Infection Prevention in Sickle Cell Anemia (ZIPS): study protocol for a randomized placebo-controlled trial in Ugandan children with sickle cell anemia
Sickle cell anemia (SCA) is the most common inherited hemoglobinopathy worldwide. Infection is a major cause of illness and death in children with SCA, especially in sub-Saharan Africa where an estimated 50–90% of affected children die before their fifth birthday. Interventions to reduce the incidence and severity of infections are needed urgently. A high proportion of adults and children with SCA are zinc-deficient, and zinc deficiency leads to impaired immunity and an increased risk of infection. Zinc supplementation has been shown to decrease the risk of infection in adolescents and adults, but there are no data on the effectiveness of zinc for prevention of infection in children < 5 years of age with SCA. The study will be a randomized, placebo-controlled, double-blind clinical trial in which 250 Ugandan children 1.00–4.99 years of age with SCA will receive daily zinc supplementation (10 mg oral dispersible tablet) or identical placebo for 12 months. If this trial shows a reduction in severe or invasive infection incidence, it would be the basis for a multi-site, multi-country clinical trial to assess real-world safety and efficacy of zinc in African children with SCA. Since zinc is safe, inexpensive, and easy to administer, this trial has the potential to improve the health of hundreds of thousands of African children with SCA through reduction of infection-related morbidity and mortality. Clinicaltrials.gov, NCT03528434. Registered on May 17, 2018 Protocol Version: 1.0. Date: Dec 11, 2017 Sponsor: Indiana University. Sponsor’s protocol identifier, 1712339562
- Open Access
- 15 November 2012
- Published by Springer Nature in Trials
- Vol. 13 (1) , 213
The Uganda Newborn Study (UNEST): an effectiveness study on improving newborn health and survival in rural Uganda through a community-based intervention linked to health facilities - study protocol for a cluster randomized controlled trial
Reducing neonatal-related deaths is one of the major bottlenecks to achieving Millennium Development Goal 4. Studies in Asia and South America have shown that neonatal mortality can be reduced through community-based interventions, but these have not been adapted to scalable intervention packages for sub-Saharan Africa where the culture, health system and policy environment is different. In Uganda, health outcomes are poor for both mothers and newborn babies. Policy opportunities for neonatal health include the new national Health Sector Strategic Plan, which now prioritizes newborn health including use of a community model through Village Health Teams (VHT). The aim of the present study is to adapt, develop and cost an integrated maternal-newborn care package that links community and facility care, and to evaluate its effect on maternal and neonatal practices in order to inform policy and scale-up in Uganda.
- 15 November 2012
- Published by Springer Nature in Trials
- Vol. 13 (1) , 213
Open AccessThe Uganda Newborn Study (UNEST): an effectiveness study on improving newborn health and survival in rural Uganda through a community-based intervention linked to health facilities - study protocol for a cluster randomized controlled trial
Reducing neonatal-related deaths is one of the major bottlenecks to achieving Millennium Development Goal 4. Studies in Asia and South America have shown that neonatal mortality can be reduced through community-based interventions, but these have not been adapted to scalable intervention packages for sub-Saharan Africa where the culture, health system and policy environment is different. In Uganda, health outcomes are poor for both mothers and newborn babies. Policy opportunities for neonatal health include the new national Health Sector Strategic Plan, which now prioritizes newborn health including use of a community model through Village Health Teams (VHT). The aim of the present study is to adapt, develop and cost an integrated maternal-newborn care package that links community and facility care, and to evaluate its effect on maternal and neonatal practices in order to inform policy and scale-up in Uganda.